Call (408) 747-0185 or Contact us

CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody

Catalog No : A0005
  • Size
    50ul
  • Price
    $175.00
Details
  • Product Name
    CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody
  • Catalog No
    A0005
  • Storage/Stability
    Stable at -20°C for at least 1 year.
  • Applications
    WB, IHC, ELISA
  • Clonality
    Polyclonal
  • Source
    Rabbit
  • Reactivity
    Human, Mouse, Rat
  • Application Dilutions
    WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:5000
  • Database Links
    Gene ID: 816/817, Swiss-Prot #: Q9UQM7/Q13554/Q13557, OMIM #: 114078/607707/607708, Unigene #: Hs.143535/Hs.351887/Hs.144114
  • Image 1
    Immunohistochemistry analysis of paraffin-embedded human brain, using CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody. The picture on the right is blocked with the phospho peptide.
  • Image 2
    Western blot analysis of lysates from NIH/3T3 cells, using CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody. The lane on the right is blocked with the phospho peptide.
  • Immunogen
    The antiserum was produced against synthesized peptide derived from human CaMK2 alpha/beta/delta around the phosphorylation site of Thr305.
  • Immunogen Range
    271-320
  • Modification Sites
    H: T305/306/306 M: T305/306/306 R: T305/306/306
  • MW
    54 kDa
  • NCBI Gene Symbol
    CAMK2A
  • Physical Form
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Purification
    The antibody was purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.
  • Specificity
    CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody detects endogenous levels of CaMK2 alpha/beta/delta only when phosphorylated at Thr305.
  • Synonyms
    CAMK2A, CaM-kinase II alpha chain, CaMK-II alpha subunit, CaMKII-alpha, Calcium/calmodulin-dependent protein kinase type II alpha chain, KCC2A, kinase CaMK2-alpha
  • Target Modification
    Phospho
Application Images
Image 1 Immunohistochemistry analysis of paraffin-embedded human brain, using CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody. The picture on the right is blocked with the phospho peptide.
Image 2 Western blot analysis of lysates from NIH/3T3 cells, using CaMK2 alpha/beta/delta (Phospho-Thr305) Antibody. The lane on the right is blocked with the phospho peptide.
  • Xiang, F., Neal, P.: Efficient MCMC for temporal epidemics via parameter reduction. Comput. Stat. Data Anal.
  • Xiang, F., Neal, P.: Efficient MCMC for temporal epidemics via parameter reduction. Comput. Stat. Data Anal.
  • Xiang, F., Neal, P.: Efficient MCMC for temporal epidemics via parameter reduction. Comput. Stat. Data Anal.
  • Xiang, F., Neal, P.: Efficient MCMC for temporal epidemics via parameter reduction. Comput. Stat. Data Anal.
  • Xiang, F., Neal, P.: Efficient MCMC for temporal epidemics via parameter reduction. Comput. Stat. Data Anal.
For the process of attaching edges to nodes, it is straightforward to compute the likelihood using (2). However, because of the nature of weighted sampling without replacement, we have to, for each i, calculate the probability conditi onal on each of the Xi!Xi! permutations of the selected nodes and then aver age over all Xi!Xi! probabilities to arrive at the likelihood. As calculating the exact likelihood in this way is not computationally feasible because the factorial grows faster than the exponential function, we approximate the likelihood based on one permutation of weighted sampling without replacement instead. The contribution by the new edges brought by node i is
Get resources and offers direct to your inbox Sign up